3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
125
Neoplasm Metastasis
17
Ovarian Neoplasms
12
Endometrial Neoplasms
9
Neoplasms
8
Triple Negative Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Hereditary Sensory and Autonomic Neuropathies
5
Colorectal Neoplasms
5
Advanced Breast Cancer
5
Squamous Cell Carcinoma of Head and Neck
4
Stomach Neoplasms
3
Recurrence
3
Neoplasms by Site
3
Head and Neck Neoplasms
3
Carcinoma, Lobular
3
Breast Diseases
3
Breast Cancer Metastatic
3
Uterine Neoplasms
2
Small Cell Lung Carcinoma
2
Multiple Endocrine Neoplasia Type 1
2
Melanoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Advanced Solid Tumors
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Interventions
Cyclophosphamide
62
Rituximab
47
fludarabine
35
fludarabine phosphate
27
obinutuzumab
17
Mycophenolic Acid
16
ibrutinib
15
Whole-Body Irradiation
15
Lenalidomide
15
Specimen Handling
14
Prednisone
14
venetoclax
13
pirtobrutinib
13
Etoposide
13
Doxorubicin
13
pembrolizumab
12
Tacrolimus
12
Magnetic Resonance Spectroscopy
11
Granulocyte Colony-Stimulating Factor
11
Filgrastim
11
Biopsy
11
Vincristine
10
Peripheral Blood Stem Cell Transplantation
10
Melphalan
10
X-Rays
9
Bendamustine Hydrochloride
9
polatuzumab vedotin
8
glofitamab
8
acalabrutinib
8
Immunotherapy, Adoptive
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Fulvestrant
×
1 year
×
Clear all
No trials found.